257 related articles for article (PubMed ID: 18278426)
21. Generation of antibodies against bovine recombinant prion protein in various strains of mice.
Andrievskaia O; McRae H; Elmgren C; Huang H; Balachandran A; Nielsen K
Clin Vaccine Immunol; 2006 Jan; 13(1):98-105. PubMed ID: 16426006
[TBL] [Abstract][Full Text] [Related]
22. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
23. The role of the 132-160 region in prion protein conformational transitions.
Torrent J; Alvarez-Martinez MT; Liautard JP; Balny C; Lange R
Protein Sci; 2005 Apr; 14(4):956-67. PubMed ID: 15772306
[TBL] [Abstract][Full Text] [Related]
24. Slow conformational dynamics in the hamster prion protein.
Kuwata K; Kamatari YO; Akasaka K; James TL
Biochemistry; 2004 Apr; 43(15):4439-46. PubMed ID: 15078089
[TBL] [Abstract][Full Text] [Related]
25. Differences between the prion protein and its homolog Doppel: a partially structured state with implications for scrapie formation.
Nicholson EM; Mo H; Prusiner SB; Cohen FE; Marqusee S
J Mol Biol; 2002 Feb; 316(3):807-15. PubMed ID: 11866533
[TBL] [Abstract][Full Text] [Related]
26. Activation of classical pathway of complement cascade by soluble oligomers of prion.
Dumestre-Pérard C; Osmundson J; Lemaire-Vieille C; Thielens N; Grives A; Favier B; Csopaki F; Jamin M; Gagnon J; Cesbron JY
Cell Microbiol; 2007 Dec; 9(12):2870-9. PubMed ID: 17991046
[TBL] [Abstract][Full Text] [Related]
27. Oligomeric forms of peptide fragment PrP(214-226) in solution are preferentially recognized by PrP(Sc)-specific antibody.
Ulrih NP; Skrt M; Veranic P; Galvani V; Vranac T; Curin Serbec V
Biochem Biophys Res Commun; 2006 Jun; 344(4):1320-6. PubMed ID: 16650818
[TBL] [Abstract][Full Text] [Related]
28. An aggregation-specific enzyme-linked immunosorbent assay: detection of conformational differences between recombinant PrP protein dimers and PrP(Sc) aggregates.
Pan T; Chang B; Wong P; Li C; Li R; Kang SC; Robinson JD; Thompsett AR; Tein P; Yin S; Barnard G; McConnell I; Brown DR; Wisniewski T; Sy MS
J Virol; 2005 Oct; 79(19):12355-64. PubMed ID: 16160162
[TBL] [Abstract][Full Text] [Related]
29. Copper induces conformational changes in the N-terminal part of cell-surface PrPC.
Leclerc E; Serban H; Prusiner SB; Burton DR; Williamson RA
Arch Virol; 2006 Nov; 151(11):2103-9. PubMed ID: 16791441
[TBL] [Abstract][Full Text] [Related]
30. Seeded conversion of recombinant prion protein to a disulfide-bonded oligomer by a reduction-oxidation process.
Lee S; Eisenberg D
Nat Struct Biol; 2003 Sep; 10(9):725-30. PubMed ID: 12897768
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
[TBL] [Abstract][Full Text] [Related]
32. Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry.
Sajnani G; Pastrana MA; Dynin I; Onisko B; Requena JR
J Mol Biol; 2008 Sep; 382(1):88-98. PubMed ID: 18621059
[TBL] [Abstract][Full Text] [Related]
33. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
34. SPR biosensor as a tool for screening prion protein binders as potential antiprion leads.
Chen B
Methods Mol Biol; 2010; 627():147-55. PubMed ID: 20217619
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
36. Scrapie-infected cells, isolated prions, and recombinant prion protein: a comparative study.
Kneipp J; Miller LM; Spassov S; Sokolowski F; Lasch P; Beekes M; Naumann D
Biopolymers; 2004 May-Jun 5; 74(1-2):163-7. PubMed ID: 15137116
[TBL] [Abstract][Full Text] [Related]
37. A role for His155 in binding of human prion peptide144-167 to immobilised prion protein.
Hesp JR; Raven ND; Sutton JM
Biochem Biophys Res Commun; 2007 Oct; 362(3):695-9. PubMed ID: 17761148
[TBL] [Abstract][Full Text] [Related]
38. Chicken antibody against a restrictive epitope of prion protein distinguishes normal and abnormal prion proteins.
Miyamoto K; Kimura S; Nakamura N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2007 Oct; 35(4):303-8. PubMed ID: 17363268
[TBL] [Abstract][Full Text] [Related]
39. De novo generation of a PrPSc-like conformation in living cells.
Ma J; Lindquist S
Nat Cell Biol; 1999 Oct; 1(6):358-61. PubMed ID: 10559963
[TBL] [Abstract][Full Text] [Related]
40. Methionine sulfoxides on PrPSc: a prion-specific covalent signature.
Canello T; Engelstein R; Moshel O; Xanthopoulos K; Juanes ME; Langeveld J; Sklaviadis T; Gasset M; Gabizon R
Biochemistry; 2008 Aug; 47(34):8866-73. PubMed ID: 18680312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
